Approval · Notice of Compliance 17713 · 2016
KINOX: Notice of Compliance 17713
Issued January 25, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 17713
- Date
- January 25, 2016
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- INOMAX (Ino Therapeutics)
Products in this notice
Medicinal ingredients
- NITRIC OXIDE 100 PPM per CYLR
- NITRIC OXIDE 800 PPM per CYLR